seragy is a provider of a biomarker strategy platform focused on neurodegenerative diseases and other proteopathies.
seragy has raised €12M across 1 funding round from 3 investors, most recently a round in Oct 2026. Based in Hanover, Germany; active in Healthtech. Data as of 15 Oct 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-10-15 | Other | €12M |
| Commerzbank,the Mittelständische Beteiligungsgesellschaft (MBG),the State of Lower Saxony |
| View deal → |
